Clear cell myoepithelial carcinoma ex pleomorphic adenoma of parotid gland: Case report and review of literature by Romano, Antonio et al.
Oral and Maxillofacial Surgery Cases 4 (2018) 12e16Contents lists available at ScienceDirectOral and Maxillofacial Surgery Cases
journal homepage: www.oralandmaxi l lofacia lsurgerycases.comClear cell myoepithelial carcinoma ex pleomorphic adenoma
of parotid gland: Case report and review of literature
Antonio Romano, Assistant professor a, Giovanni Dell'Aversana Orabona,
Assistant professor a, Antonio Pansini, Resident a, *, Giovanni Salzano,
Resident a, Immacolata Cozzolino, Assistant professor c, Miriam Cieri,
Resident c, Giorgio Iaconetta, Assistant professor b, Luigi Califano, Full
professor, Director a
a Department of Maxillofacial Surgery, University of Naples Federico II, Naples, Italy
b Department of Neurosurgery, University of Salerno, Salerno, Italy
c Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italya r t i c l e i n f o
Article history:
Received 9 November 2017
Received in revised form 25 December 2017
Accepted 28 December 2017
Available online 30 December 2017
Keywords:
Myoepithelial carcinoma
Neoplasms
Parotid gland
Salivary gland* Corresponding author.Department of Maxillofac
E-mail address: a.pansini86@gmail.com (A. Pans
https://doi.org/10.1016/j.omsc.2017.12.002
2214-5419/© 2017 Published by Elsevier Inc. This is
4.0/).a b s t r a c t
Myoepithelial carcinoma (MC), also known as malignant myoepithelioma, shows an
inﬁltrative and destructive growth [1]. Myoepithelial neoplasms account for about 1.5% of
all salivary tumors, and MC is even more rare, representing about 10% of myoepitheliomas
[1e3] with a reported incidence of 0.2% of all salivary gland tumors. In this case, the
cytological diagnosis (pleomorphic adenoma) and negative lymph nodes, addressed the
surgeon for a parotidectomy, following guidelines and literature [27]. The best treatment
for huge, relapsing tumors, notwithstanding cytological diagnosis, is not only parotidec-
tomy, as lymphadenectomy should be performed too, given myoepithelial carcinoma's
high-grade potential and unpredictable biologic behavior. Careful patient follow-up and
staging, is therefore essential for better characterization and understanding of this tumor's
behavior in the future. We also considered a more conservative treatment following
guidelines, as this case was lacking metastases and lymphatic involvement, considering
that application of guidelines, surgical and clinical expertise and appropriate technology
can contain potential medicolegal implications [28].
© 2017 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Myoepithelial neoplasms are tumors composed of cells with myoepithelial differentiation. Most behave in a benign
fashion and are designated myoepithelioma. Myoepithelial carcinoma (MC), also known as malignant myoepithelioma, is the
malignant counterpart of benign myoepithelioma, from which is distinguished by its inﬁltrative, destructive growth [1].
Myoepithelial neoplasms account for about 1.5% of all salivary tumors, and MC is even more rare, representing about 10% of
myoepitheliomas [1e3] with a reported incidence of 0.2% of all salivary gland tumors [4]. However, some Authors contend
that myoepithelial carcinoma (malignant myoepithelioma) may not be as rare as previously suggested [2,5], as a lack ofial Surgery, University of Naples Federico II, via Pansini 5, Naples, 80131, Italy.
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cases. It was ﬁrst described by Stromeyer et al., in 1975 [6] and Barnes et al. renewed interest in this tumor in 1985, describing
3 cases of myoepithelial carcinoma in their review of head and neck myoepitheliomas [7]. Dardick et al. furthered the un-
derstanding of myoepithelial tumors [8,9] increasing the accuracy of describing reported cases of myoepithelial carcinoma.
This kind of tumor was added to the second edition of the World Health Organization (WHO) classiﬁcations of malignant
salivary gland tumors in 1991 [11]. Many of these tumors arise as a malignant transformation in the setting of a benign
pleomorphic adenoma or a benign myoepithelioma [12e18], and myoepithelial carcinoma is particularly seen in association
with recurrence of these benign tumors. Other tumors like this arise de novo [12,13,19].
The differential diagnosis of clear cell salivary neoplasms includes clear cell myoepithelial carcinoma (CCMEC), primary
salivary clear cell tumors (CCC), epithelial-myoepithelial carcinoma (EMEC), and clear cell variants of other salivary tumors,
including acinic cell carcinoma, oncocytoma, mucoepidermoid carcinoma and myxoﬁbrosarcoma [10]. Also metastatic tu-
mors, such as renal cell carcinoma or balloon cell melanoma, are a consideration [19e21].
2. Case report
A 60-year-old female referred to our Department ofMaxillofacial Surgery on February 2017with a 2 years duration gradual
painless mass in the right parotid region. This patient had already a history of pleomorphic adenoma in the same region,
treated in 2000 and in 2010 by enucleation, after relapse. On inspection, hyperemic skin coating the mass. On palpation, a
painful tender-elastic mass of about 2 2,5 cm, adherent to the skin and deep tissues. Facial nerve was not involved.
The patient had already undergone, in December 2016, an ultrasound of the right parotid region and the structural
appearance was that of a big nodular, iso-hypoechogenic formation of 1,51.0 cm. Computed tomography (CT) scan, per-
formed in February 2017, showed a 2.5 3 cm oval area in the right parotid gland [Fig. 1]. Moreover, the mass was dish-
omogeneously enhanced with contrast. No metastatic cervical node was showed. Then, a ﬁne-needle aspiration was
performed. Cytology revealed evidence of pleomorphic adenoma. The analysis showed hypercellularity with not atypical,
incohesive and cohesive areas.
The patient underwent a radical right parotidectomy with resection of the facial nerve, and preservation of one branch of
the temporozygomatic branch was performed [Fig. 2aeb and 3aeb]. Because of the deep adherence of the tumor to the
remaining part of the facial nerve, it could not be preserved. SMAS ﬂap reconstruction was then done. No lymphadenectomy
was performed, given the benignity of the pleomorphic adenoma resulting from the cytology.
Histology disclosed, on superﬁcial parotidectomy slices, a multinodular, mixed tumor, with epithelial e myoepithelial
pleomorphic adenoma areas and clear cell myoepithelial areas (see Fig. 4). This last ﬁnding is considered as an expression of
the clear cell myoepithelial carcinoma, given the proliferation of the salivary glands and the plurinodular growth interesting
the surrounding tissues. On deep parotidectomy slices, histology disclosed a predominantly stromal component of pleo-
morphic adenoma, comparable to the cytological diagnosis.
Tumor cells were negative for HMB45 (monoclonal antibody that reacts against antigen present in melanocytic tumors
such as melanomas), CD10 (cluster of differentiation which excluded the possibility of metastasis of renal clear cell adeno-
carcinoma) DOG-1 (tubular and cribriform predominant adenoid cystic carcinoma are more frequently DOG1 positive) and
CD68. Immunohistochemical stains revealed that the tumor cells were positive for S100 protein and CK (cytokeratin) 18
(myoepithelial component), CK 8 (epithelial component).
In the case described here, only postoperative frozen section conﬁrmed the malignant nature of this rare neoplasm. Of
course FNAB can conﬁrm the malignant nature of such neoplasm but, when not corresponding to the imaging, it shouldFig. 1. Cervical CT showing a 2.5 3 cm ovalar area in the right parotid gland.
a)                                                                                                               b)
Fig. 2. (a) Preoperative photograph of the tumor, (b) Intra-operative photograph showing the area after right parotidectomy.
Fig. 3. Surgical specimen. (a) Gross photograph showing a multinodular grey-white tumor in the parotid parenchyma. (b) Deep parotidectomy.
Fig. 4. Histological examination: (a) a glandular epithelial component and mixoid stroma of the pleomorphic adenoma adjacent to the normal salivary gland; (b)
a multinodular pattern constituted by a clear cell component. Inset: higher magniﬁcation shows large vacuolated cells with dislocated nuclei and clear cytoplasm.
A. Romano et al. / Oral and Maxillofacial Surgery Cases 4 (2018) 12e1614address the surgeon for further evaluation to best treat the patient, mostly in patients with a relapsing, huge dimension
pleomorphic adenoma diagnosis. The best treatment for such malignancy, as a matter of fact, is not only parotidectomy, as
lymphadenectomy should be performed, too.3. Discussion
In the past, myoepithelial carcinomas (MC) have been underrecognized, primarily by being lumped under a broader
category of “malignant mixed tumor.” Awareness of their peculiar cytoarchitectural patterns and immunohistochemical
proﬁle is fundamental for accurate identiﬁcation [1e3]. MC, also known as malignant myoepithelioma, is a rare, aggressive
primary salivary gland neoplasm, accounting for less than 1% of all salivary gland tumors.
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neoplastic cells with myoepithelial differentiation and characterized by inﬁltrative growth and potential for distant metas-
tasis [2,5].
The mean age of presentation is about 55 years and there is no preference for sex. Thetumor usually appears as an
asymptomatic mass that slowly increases in size [6]. Histologically, myoepithelial carcinomas are variously composed of one
or different cell types: plasmacytoid, spindle, epithelioid, and clear cells. Frequently, one type of cells predominates. The
neoplastic cells grow either as multiple nodules or as large solid sheets separated by variable amounts of interposing hyaline
or myxoid stroma. The cytological patterns in FNABs [7e9], generally reﬂect the histology. The cytological smear can show
epithelioid, spindle, or plasmacytoid cells. Scant fragments of metachromatic stroma intermixed with neoplastic cells might
be observed in the cytological specimens, regardless the composition of the cell types.
MC exhibits a propensity for distant metastasis more than for regional lymph node metastasis [22], with an ability for
extensive local growth, inﬁltration, and destruction [15,22]. Distant metastasis has been seen to the lungs (most commonly),
bone, liver, peritoneum, pleura, kidney, brain, and skin [7,18,23e25]. So, MC is an aggressive tumor that is associated with a
high rate of distant metastasis and, compared with de novo myoepithelial carcinoma, carcinoma ex-pleomorphic adenoma
correlates with worse clinical outcome [25]. Prognostic reports onMC are generally limited. Surgery is the ﬁrst line treatment,
either for recurrent, or distant metastatic or lymph node metastatic tumors. Postoperative radiotherapy is used in metastatic
tumors, with scarce beneﬁts from chemotherapy [2,22e28].
With around 50% to over 65% survival from cases that were followed-up in reported series, myoepithelial carcinoma
should probably best considered a tumor with high-grade potential and unpredictable biologic behavior. Careful patient
follow-up and staging is therefore essential for better characterization and understanding of this tumor's behavior in the
future.
Differential diagnoses of myoepithelial carcinoma include: spindle cell neoplasms (eg, leiomyosarcoma, schwannoma,
spindle cell squamous cell carcinoma, metaplastic carcinoma, metastatic malignant melanoma); tumors with clear cell
morphology (eg, epithelial-myoepithelial carcinoma, hyalinizing clear cell carcinoma, mucoepidermoid carcinoma, meta-
static renal cell carcinoma, clear cell carcinoma of salivary glands); tumors with epithelioid morphology (eg, adenocarcinoma,
adenoid cystic carcinoma, metastatic malignant melanoma); tumors with plasmacytoid morphology (eg, plasmacytoma,
malignant melanoma, lymphomas, medullary thyroid carcinoma, myxoﬁbrosarcoma [10].
4. Conclusion
As ﬁrst step, this citologically deﬁned pleomorphic adenoma of parotid was treated in our Department, as recommended
in literature for pleomorphic adenomas [27,31,33], by parotidectomy. In fact, this kind of lesion should be treated conser-
vatively when clinical and imaging ﬁndings do not address the surgeon for a malignant diagnosis, lacking metastases and
lymphatic involvement. Proper treatment of this kind of lesion is mandatory, as surgical errors and complications in neck
surgery are a relevant clinical issue. Only the combination of surgical and clinical expertise, application of guidelines, and
appropriate technology can contain potential medicolegal implications [28] and post surgical complications [32]. Though, in
this case, the frozen section diagnosis did not correspond to the cytological diagnosis, as 60%e70% of MC develops in a benign
mixed tumor [1,2]. The myoepithelial clear cell tumor diagnosis, deriving by frozen section analysis, corresponded to the
typical aspect, described in literature [29], we observed in CT scans the patient underwent before surgery. Myoepithelial
carcinoma has, in fact, characteristic pathologic features and computed tomography imaging findings, including an irregularly
lobulated or multinodular lesion with ill-defined margins, moderate and intense inhomogeneous enhancement, intensely
enhanced nodules, and small tortuous vessels. Myoepithelial carcinomas arising within a preexisting benign tumor should be
suspected if there is long history of benign parotid tumor with history of rapid growth and/or multiple recurrences in a
preexisting pleomorphic adenoma with or without lymph node metastasis [30]. In big, relapsing tumors, notwithstanding
cytological diagnosis and negative lymph nodes, it is legit to suspect there is some grade of variability in malignant cells, such
as those of myoepithelial carcinoma. So, in our experience, we suggest all these factors should address the surgeon for a more
appropriate treatment, consisting in a parotidectomy plus omolateral lymphadenectomy.
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